Medical beauty has dual attributes of medical treatment and consumption. With the continuous promotion of doctors' multi-point practice policy and consumption upgrade, by 20 15, there will be about 5,000 active medical beauty institutions in China, and the medical beauty market will reach 50-10 billion. In recent years, the growth rate of the industry has reached 20%-30%, which is higher than the average growth rate of the traditional medical industry.
From 1998 to 20 16, there were 779 upstream and downstream investments in the industrial chain of China medical and beauty industry, of which 67 1 transaction was disclosed. The total disclosed investment amount is 54.088 billion yuan, with an average investment amount of 806 1 ten thousand yuan. From 200 1 to 20 10, the medical beauty industry still belongs to the development period. Since 20 10, the investment scale of medical and beauty industry has also increased rapidly. The number of investment cases in 20 15 reached 249, which was more than 15 times that in 2008.
From 200 1 to 20 16, there were 302 M&A incidents in the medical and beauty industry in China, with a total amount of 68.06 billion RMB, with an average cost of 225 million RMB. According to the upstream and downstream distribution of the medical and beauty industry, there were 43 M&A incidents in the upstream R&D and production of medicines and medical devices. M&A in the middle and lower reaches of medical institutions and medical device sales 159, with a total amount of RMB 3,365,438+32 million. The total number of M&A cases in 200 1-20 10 is small, but there are several large-scale M&A cases, and the industry is still in the development stage. 20 1 1-20 16, M&A fever began to develop, M&A cases increased, and M&A quantity continued to rise.
The upstream of medical beauty industry mainly includes medical device manufacturers and material consumables manufacturers. From upstream to midstream, there are middlemen, usually agents and distributors. The middle reaches of the medical beauty industry mainly include the beauty department of public hospitals, private beauty hospitals and beauty salons. At present, the market of medical beauty industry is chaotic, the quality of service institutions in the middle reaches is uneven, there are few public hospitals with brand effect, a national brand chain company has not yet been formed, and there are problems of irregular operation. The middle and lower reaches of the medical beauty industry are shopping guide platforms, search engines and medical beauty apps. Because the domestic medical and beauty industry relies too much on the marketing model, there are various intermediaries between medical service institutions and consumers. In recent years, with the rise of mobile Internet, the medical beauty APP platform represented by new oxygen has been launched, which has established a direct communication bridge between beauty hospitals and consumers, and is expected to rebuild the ecosystem in the industry, compress intermediate links and improve the efficiency of beauty resource allocation.
From the horizontal analysis of the upper, middle and lower reaches of the medical and beauty industry, the industry supervision of upstream manufacturers is relatively standardized, the industry is relatively concentrated, and the profits are mainly concentrated in the upstream, especially the leading companies have higher profit margins. However, in the medium and long term, there is more room for the integration and upgrading of the middle and lower reaches of the terminal, which may become the main battlefield for all parties in the future. From the perspective of the vertical extension of the whole industrial chain, the medical beauty industry began to connect with industries such as culture, entertainment and advertising media. After years of development, the medical beauty industry has formed an interdisciplinary industry covering many aspects, including medical research department, medical institutions/equipment industry, beauty service industry, culture and entertainment industry and so on. As a cross-industry, medical beauty industry has a broad market dimension, which provides a larger platform for more participants to realize value.
Medical beauty O2O solves the problem of information asymmetry in the traditional medical beauty industry, effectively solves the pain points of consumers, doctors and medical beauty institutions, creates customers for hospitals at a lower cost, creates commercial value, and wins the favor of capital. The popularity of medical beauty in Chinese mainland market is not as good as that in Taiwan Province Province of South Korea. In South Korea and Taiwan Province Province, medical beauty knowledge is mainly popularized by stars and talents. By simplifying professional terms, TV programs, celebrity books and other forms, the public can feel close to medical beauty and shorten the psychological distance between professional medical care and the audience. There is a lack of supervision mechanism for advertisements in medical beauty industry in Chinese mainland, which exaggerates that false advertisements occupy hot searches and streets. The chaos in the industry makes people have a bad impression on medical beauty as a whole. It is difficult for customers with cosmetic needs to find reliable medical resources in China. Therefore, customers with better economic strength mostly turn to South Korea and Taiwan Province Province to go abroad for cosmetic surgery. There are many cases in which customers who receive domestic service are blackmailed, surgery fails, and they cannot appeal after surgery.
It is the most important thing to improve the industry chaos, reshape the medical and aesthetic industry structure, and solve the information exchange problem between customers and medical service institutions. On the one hand, Medical Beauty O2O links professional medical beauty institutions, such as cosmetic departments of 3A hospitals, doctors' groups such as United Li Ge, offline clinics, and small and medium-sized plastic surgery institutions to provide customers with multi-level and reliable medical institution choices. On this basis, the price of medical beauty is open, which makes the industry charges more transparent. By providing customers with reasonable prices through group purchase and discount, the reliability of medical beauty is improved, the entry threshold is lowered, and more customers are willing to try medical beauty services and form diversion. Medical beauty O2O not only provides the docking service between customers and professional organizations, but also opens a consultation window, where professional customer service or a team of doctors can answer customers' questions in time, follow up postoperative services and improve customer satisfaction. At the same time, a number of medical beauty O2O have formed a lot of word-of-mouth feedback and experience sharing through the establishment of beauty communities, which not only stabilized some high-frequency consumer customers, but also provided reference for entry-level customers, and restrained the service quality of medical institutions from the client side. Medical beauty O2O plays an irreplaceable role in popularizing medical beauty knowledge, meeting the needs of customers and institutions, improving customer experience, standardizing industry service quality, and promoting the formation of healthy competition pattern in the industry.
There are three major investment opportunities in the medical beauty industry: material/equipment manufacturers, private medical beauty hospitals, and medical beauty O2O.
Based on the above analysis, we believe that the medical and beauty industry in China has entered the primary stage of rapid development, and now is the best time to invest. From the upstream and downstream of the industrial chain, there are three aspects worthy of attention: first, the research and development and manufacturers of beauty materials and equipment; Second, private beauty hospitals; The third is medical beauty O2O. Beauty materials and equipment manufacturers, as the main suppliers of raw materials in the upstream of the industry, are expected to replace imported products with low price advantages with the improvement of technology and product quality in the future, which will provide a strong guarantee for the rapid development of China's medical beauty market; As a provider of beauty services, private hospitals directly meet the needs of consumers. With the standardization of industry competition order, some enterprises will inevitably win by virtue of first-class technology, high-quality service and safe products, and become well-known brand medical beauty service providers in China. Medical beauty O2O can change the pain points of the current medical beauty industry, greatly shorten the distance between beauty hospitals and potential customers, and thus reduce the cost of obtaining customers.
The world medical beauty industry is growing, and the global beauty plastic surgery market is also growing.
According to the research report of Guohai Securities, worldwide, after entering the 2 1 century, the world medical and beauty industry has become the third largest industry after the automobile industry and aviation industry. In 20 14, the global cosmetic surgery market reached $34.6 billion. Based on the growth trend of the global cosmetic and plastic surgery consumer market in recent years, it is estimated that one third of the world's top 500 enterprises will be engaged in the research, development, production and sales of medical cosmetic technology.
On the supply side, the number of 20 14 plastic surgeons has gradually increased, and the total number of plastic surgeons in the world has exceeded 40,000. There are 6,300 plastic surgeons in the United States, ranking first in the world, accounting for15.6% of the total; China ranks third. The development speed of plastic surgeons reflects the development speed of plastic surgery industry in this country from one side. The plastic surgery industry in the United States, Brazil and other countries has gradually matured, and the number of plastic surgeons is very stable. From the demand side, according to ISAPS (International Society of Plastic Surgery) statistics, in 20 14, there were 4,064,500 cases of plastic surgery consumption in the United States, accounting for 20 1% of the global total, while in 20 15, the plastic surgery market in the United States had reached $5 billion in plastic surgery products sales and/kloc-0. Brazil's plastic surgery consumption * * * is 2058530 cases, accounting for 10.2% of the global total.